There is a need for FAAH inhibitors capable of oral administration and having excellent efficacy, particularly agents for the prevention and treatment of pain. Disclosed are novel arylurea compounds represented by formula (I), salts or solvates thereof, and pharmaceutical compositions comprising the same as an active ingredient. The pharmaceutical composition is used primarily for FAAH inhibitors, or agents for prevention and treatment of pain.
需要口服能力强且具有出色疗效的FAAH
抑制剂,尤其是预防和治疗疼痛的药物。公开了一种新型芳基
脲化合物,其表示为式(I),其盐或溶剂化物以及包含其作为活性成分的制药组合物。该制药组合物主要用于FAAH
抑制剂,或预防和治疗疼痛的药物。